Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04190628
Title Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ABM Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California- San Francisco San Francisco California 94158 United States Details
Stanford University School of Medicine Stanford California 94305 United States Details
University of Miami Hospital Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
Robert H. Lurie Comprehensive Cancer Center (Northwestern University) Chicago Illinois 60611 United States Details
Henry Ford Cancer Institute Detroit Michigan 48202 United States Details
Columbia University Medical Center New York New York 10032 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
UTHealth Science Center Houston Department of Neurosurgery Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field